Analyst Research Report Snapshot

Title:

Novozymes A/S

Price:

$50.00

Provider:

MarketLine (a Datamonitor Company)

Date:

26 Nov 2013

Pages:

39

Type:

AcrobatPDF

Companies referenced:

NZYMb.CO

Available for Immediate Download
Summary:

Novozymes A/S - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Novozymes A/S required for business and competitor intelligence needs - Intelligence on Novozymes A/S’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Novozymes A/S, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Novozymes is a bioinnovation company engaged in the development, production, distribution, and sale of enzymes, microorganisms, and biopharmaceutical ingredients. It offers a range of industrial enzymes, such as detergent enzymes for detergents; technical enzymes for the transformation of starch into sugars; food enzymes for the food and beverage industries; and feed enzymes for the use in animal feed. The company also focuses on developing new microorganisms and biopharmaceutical ingredients for drug delivery and formulation, and renewable chemicals. Novozymes operates in Europe, Americas, Europe and Asia Pacific. It is headquartered in Bagsvaerd, Denmark and employs around 5,432 people. The company recorded revenues of DKK9,724 million (approximately $1,733.6 million) in the fiscal year ended December 2010, an increase of 15.1% over 2009. The company's operating profit was DKK2,117 million (approximately $377.4 million) in fiscal 2010, an increase of 25.4% over 2009. Its net profit was DKK1,613 million (approximately $287.6 million) in fiscal 2010, an increase of 35.1% over 2009. Reasons to Purchase: - Gain understanding of Novozymes A/S the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Novozymes A/S as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Novozymes A/S your competitors' business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.